West Virginia Code of State Rules › Agency 24 - Osteopathic Medicine › Title 24 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF OSTEOPATHIC MEDICINE › Series 24-07 - Practitioner Requirements for Controlled Substances Licensure and Accessing the West Virginia Controlled Substances Monitoring Program Database › Section 24-7-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
2.1. As used in this rule, the following
				words and terms have the following meaning:
2.1.a. Administering - The direct application
				of a drug to the body of a patient by injection, inhalation, ingestion or any
				other means.
2.1.b. Benzodiazepine
				- A class of medicines approved to treat generalized anxiety disorder,
				insomnia, seizures, social phobia, and panic disorder.
2.1.c. Board - The West Virginia Board of
				Osteopathic Medicine.
2.1.d.
				Controlled Substance - A drug that is classified by federal or state law in
				Schedules I, II, III, IV or V, as defined in W. Va. Code §§
										60A-2-204
				through 212.
2.1.e. Controlled
				Substances License - A registration to dispense controlled substances in the
				state of West Virginia issued by the West Virginia Board of Osteopathic
				Medicine.
2.1.f. CSMP - The West
				Virginia Controlled Substances Monitoring Program repository and
				database.
2.1.g. DEA Registration
				Identification Number - The federal Drug Enforcement Administration
				registration identification number issued to a practitioner.
2.1.h. Dispensing - The preparation and
				delivery of a drug to an ultimate user by or pursuant to a lawful order of a
				practitioner, including the prescribing, packaging, labeling, administering or
				compounding necessary to prepare the drug for that delivery.
2.1.i. Medical Records - Records including
				the medical history and physical examination; diagnostic, therapeutic and
				laboratory results; evaluations and consultations; treatment objectives;
				discussion of risks and benefits; informed consent; treatments; medications
				(including date, type, dosage and quantity provided); instructions and
				agreements; and periodic reviews.
2.1.j. Opioid - Natural and semi-synthetic
				derivatives of the opium poppy, as well as similarly synthetic compounds that
				have analgesic or pain-relieving properties because of their effects in the
				central nervous system. These include, but are not limited to, codeine,
				morphine, hydromorphone, hydrocodone, oxycodone, methadone and
				fentanyl.
2.1.k. Patient - A person
				presenting himself or herself for treatment who is not considered by the
				practitioner as suffering from a terminal illness.
2.1.l. Practitioner - An osteopathic
				physician or physician assistant who possesses a valid DEA registration
				identification number and who is licensed by the Board pursuant to W. Va. Code
				§
										30-14-1
et seq.
or W. Va. Code §
										30-3E-1
et seq.
, or who holds an interstate telehealth registration
				issued by the Board pursuant to W. Va. Code § 30-1-26.
2.1.m. Provision - Prescribing or dispensing,
				including administering.
2.1.n.
				Terminal Illness - An incurable or irreversible condition as diagnosed by the
				attending physician or a qualified physician for which the administration of
				life-prolonging intervention will serve only to prolong the dying
				process.
2.1.o. "Website" or
				"Board's website" means the set of related web pages operated by or on behalf
				of the West Virginia Board of Osteopathic Medicine located at the domain name
www.wvbdosteo.org
, or at any successor
				domain name published by the Board.